Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease

Acta Dermato-Venereologica

Volumn 91, Issue 4, 2011, Pages 444-446

  Bassukas, Ioannis D ^a   Kosmidou, Maria ^b   Gaitanis, Georgios ^a   Tsiouri, Georgia ^a   Tsianos, And Epameinondas ^b  

^a University Campus   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Biologics; Inflammatory bowel disease; Psoriasis; Tuberculin skin test; Tuberculosis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; FEMALE; HUMAN; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; TUBERCULIN TEST; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTITUBERCULAR AGENTS; BIOLOGICAL PRODUCTS; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; FALSE POSITIVE REACTIONS; FEMALE; GREECE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PSORIASIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79958797341     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1106     Document Type: Article

References (15)

1. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Resp Crit Care Med 2000; 161: 1376-1395.
2. Doherty SD, Van Voorhees A, Lebwohl MG, korman NJ, Young MS, Hsu S, et al. National psoriasis foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol 2008; 59: 209-217.
3. Theis VS, Rhodes JM. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2008; 27: 19-30.
4. Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pasqual-Gómez E, Mola EM, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthr Reumat 2005; 52: 1766-1772.
5. Tsiouri G, Gaitanis G, kiorpelidou D, Dionysiou A, Efthymiou A, Daskalopoulos G, et al. Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis. Dermatology 2009; 219: 119-125.
6. World Health Organization. Global Tuberculosis Database. [cited 2010 Aug 12]. Available from: http://www.who.int/ tb/publications/global_report.
7. Provenzano G, Ferrante MC, Simon G. TB screening and anti-TNF-α treatment. Thorax 2005; 60: 613.
8. Bos JD, De Rie MA, Teunissen MBM, Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005; 152: 1098-1107.
9. Rambukkana A, Das Pk, Witkamp L, Yong S, Meinardi MM, Bos JD. Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 1993; 100: 87-92.
10. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
11. Morel C, Badell E, Abadie V, Robledo M, Setterblad N, Gluckman JC, et al. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specifc T cell responses in humans and mice. Eur J Immunol 2008; 38: 437-447.
12. Nestle FO, Conrad C, Tun-kyi A, Homey B, Gombert M, Boyman O, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-a production. J Exp Med 2005; 202: 135-143.
13. Jansen PAM, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jong GJ, et al. β-defensin-2 protein is a serum biomarker or disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin. PLoS ONE 2009; 4: e4725.
14. Rivas-Santiago B, Schwander SK, Sarabia C, Diamond G, Klein-Patel ME, Hernandez-Pando R, et al. Human β-defensin 2 is expressed and associated with Mycobac-terium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 2005; 73: 4505-4511.
15. Sánchez-Moya AI, Daudén E. Diagnosing latent tuberculosis infection in psoriatic patients under anti-TNFα treatment. Every new solution breeds new doubts. Br J Dermatol 2011; 164: 208-209.